Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q4 2023 call → NOWe need to determine if the transcript shows management explaining momentum/trajectory by pointing to a wave of building/equipping/capacity-creation by others, with the company already supplying part of that, and the wave being early. Let's analyze the transcript. The company is Apyx Medical, selling Renuvion technology for cosmetic surgery (liposuction, skin tightening). They sell generators and handpieces. Key points from management: - They discuss capital equipment environment being challenging, with prospective customers delaying purchases due to macroeconomic uncertainty and high interest rates. - They mention that customer utilization remains strong, and they expect growth in handpieces. - They talk about GLP-1 drugs as a long-term tailwind, bringing new patients into the funnel for body contouring procedures. - They mention that liposuction procedures grew 21% year-over-year to 2.3 million in 2022, and they see this as a tailwind. But is there any mention of others building new capacity? The question is about "a wave of new building, equipping, or capacity-creation being undertaken by other parties" - e.g., customers (surgeons) building new practices, expanding facilities, etc. The transcript does not mention surgeons building new clinics or expanding capacity. It talks about demand for procedures, but not about construction or capacity creation. Management talks about their own new products (Micro Handpiece), their own marketing, their own sales team reorganization, their own balance sheet. They talk about the market environment being challenging for capital equipment purchases. They mention that the pipeline is strong, but doctors are delaying purchases. That is not about others building. They mention GLP-1 drugs as a tailwind, but that is about patient demand, not about capacity creation by others. They mention that liposuction procedures are growing, but that is demand for procedures, not building of new facilities. There is no mention of surgeons or hospitals building new facilities, expanding operating rooms, or any kind of infrastructure build-out. The company sells capital equipment (generators) and consumables (handpieces). The demand for generators is currently soft because doctors are delaying purchases. So the company is not seeing a wave of capacity creation. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.